Global And U.S. Medical Disposables Market Analysis & Forecast: 2026-2033
The global and U.S. medical disposables market is anticipated to grow at a CAGR of 4.8% with USD 72.3 Mn in 2026 and is expected to reach USD 98.3 Mn in 2033. Increased focus on hygiene, safety, growing incidence of chronic diseases, growing aging population and rising surgical procedures has estimated to drive the market growth over the forecast period. In 2026, medical disposables are crucial for infection prevention as about 1 in 10 patients globally acquires a healthcare‑associated infection (HAI) in healthcare settings, with higher rates in low/middle‑income countries. WHO estimates millions of antibiotic‑resistant infections annually worldwide linked to healthcare. In the U.S., 1 in 31 hospital patients has an HAI on any given day, highlighting sustained demand for disposable infection‑control products.
Source: WHO
Nonwoven Medical Disposables is projected to account for the largest share of medical disposables in 2026, representing approximately 40.0% of the total volume. Nonwoven medical disposables lead the market due to their critical role in infection control and procedural safety across healthcare settings. These products such as surgical gowns, masks, drapes, and protective apparel are essential for preventing pathogen transmission during surgeries and patient care. The U.S. Centers for Disease Control and Prevention (CDC) reports that proper use of PPE, including non‑woven items, significantly reduces healthcare‑associated infections (HAIs), which affect approximately 1 in 31 hospitalized patients on any given day, driving sustained demand. Similarly, the World Health Organization (WHO) highlights those safe surgical practices, including barrier protection, are key to reducing postoperative infections globally. The widespread adoption of strict infection prevention protocols in hospitals worldwide continues to underpin the dominant share of non‑woven disposables.
To learn more about this report, Download Free Sample
Based on end user, hospitals dominate the market, accounting for a significant 55.0% share in 2026, as hospitals perform highest volume of procedures that require single‑use items for infection control, surgery, diagnostics, and patient care. In October 2024, according to the World Health Organization, approximately 85 % of all healthcare waste is non‑hazardous and largely composed of plastic single‑use disposables, indicating extensive disposable use in clinical settings. U.S. hospitals generate around 14,000 tons of waste per day, with 20‑25 % plastic disposables, highlighting their central role in consumables demand.
Furthermore, according to the World Health Organization (WHO), healthcare waste globally generates 16 million tons annually, of which a significant proportion is non-hazardous medical disposables such as gloves, syringes, and catheters. In the U.S., the CDC reports that hospitals handle about 36% of the total healthcare-associated infection cases, further driving the demand for disposables to maintain hygiene and safety in clinical settings.
High prevalence of chronic and communicable diseases significantly drives growth in the global and U.S. medical disposables market because ongoing care, diagnostics, injections, wound management, and infection control require single‑use products. In the U.S., CDC data show that in 2023 about 76.4% of adults (≈194 million people) had at least one chronic condition and 51.4% had multiple chronic conditions, escalating healthcare utilization across hospitals and outpatient settings. Chronic disease care accounts for the majority of U.S. healthcare costs and services, underpinning sustained demand for syringes, IV sets, gloves, catheters, and dressings. Globally, WHO continues to report that noncommunicable diseases remain the leading cause of death and disability, representing a major long‑term care burden that supports disposables usage in both routine and critical care settings.
In 2025, according to the data published by the World Health Organization, globally, over 10 million cancer diagnoses were recorded in 2025 escalating the need for diagnostic disposables like biopsy kits and treatment consumables such as chemotherapy administration sets. With more patients requiring routine care, diagnostics, and surgical support, these medical disposables are critical in ensuring hygiene, safety, and efficiency in healthcare delivery.
Rising hospitalization rates directly increase demand for medical disposables because each inpatient stay and acute care episode requires consumables such as gloves, masks, syringes, and wound care supplies. According to the data published by the Centers for Disease Control and Prevention (CDC) in the U.S., emergency departments report 17.8 million hospital admissions and 3.1 million critical care admissions, underscoring extensive inpatient care utilization requiring disposables. Additionally, according to the data published by the Centers for Disease Control and Prevention respiratory disease burdens such as influenza, and RSV continue to contribute to hospital strain; in the 2025‑26 respiratory season, peak combined hospitalization rates reached 16.6 per 100,000 people (lower, but within 20% of prior seasonal peaks). Globally, ongoing infectious disease hospitalizations highlight continual clinical care needs, reinforcing sustained medical disposable usage.
Rising hospital/clinic setups in emerging markets and increased healthcare spending boost overall disposables demand has driven the global and U.S. medical disposables market growth over the forecast period. Expansion of healthcare infrastructure remains a key growth driver for the global medical disposables market because more facilities and capacity translate into higher consumption of single‑use products in patient care, surgery, and infection prevention. For instance, in February 2026, according to the American Hospital Association (AHA) Fast Facts on U.S. Hospitals, the United States has approximately 6,100 hospitals with 907,216 staffed beds, serving tens of millions of patients annually, which drives consistent demand for syringes, gloves, catheters, IV sets, and dressings. Additionally, Organisation for Economic Co-operation and Development (OECD) data show that OECD countries allocated around 9.3% of GDP to health in 2024, and public sources financed an average 72% of healthcare spending, reflecting rising investment in facilities, equipment, and services. This sustained expansion of physical infrastructure and funding underpins increased utilization of disposables across inpatient, outpatient, and emergency care settings.
As countries invest in expanding service capacity and upgrading existing facilities including new hospitals in underserved regions and renovation of older units the throughput of patients and complexity of procedures increases, directly driving higher utilization of medical disposables critical for safety, efficiency, and infection prevention.
|
Current Event |
Description and its Impact |
|
IMDRF Regulatory Harmonization Initiatives |
|
|
WHO World Hand Hygiene & Infection Prevention Campaigns |
|
|
U.S. National Quality Strategy Emphasis on Safety |
|
|
FDA REdI Annual Conference 2026 – Focus on Innovative Regulation |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Source: CDC
To learn more about this report, Download Free Sample
North America account 35.5% market share in 2026, supported by large healthcare expenditure and extensive clinical infrastructure. According to the data published by the U.S. Centers for Medicare & Medicaid Services, in the United States, national health spending reached US$5.3 trillion in 2024, accounting for 18 % of GDP, with hospital care expenditure at US$1.63 trillion, highlighting heavy utilization of medical supplies. In 2026, according to the data published by the American Hospital Association, the region also has a substantial hospital system, with 6,100 hospitals nationwide, supporting consistent demand for disposable products in surgical and procedural care. High healthcare service usage, regulatory emphasis on infection control, and advanced medical supply chains further reinforce North America’s dominance.
The Asia-Pacific region is poised to be as the fastest-growing region through 2026-2033, owing to rapidly expanding healthcare demand due to demographic shifts and rising chronic disease burden. The region accounts for nearly 60 % of the global ageing population, with ageing driving increased utilization of medical services and disposables for both acute and long‑term care. By 2050, one in four people in Asia and the Pacific will be over 60 years old, intensifying medical care needs and consumables usage. Additionally, medical infrastructure growth evidenced by multinational firms expanding in the region, such as Create Medic’s new India sales and planned ₹100 crore manufacturing investment reflects industry confidence in Asia‑Pacific demand.
The U.S. medical disposables market dominates North America given its due to its large and advanced healthcare infrastructure, high procedure volumes, strong regulatory emphasis on infection control, significant chronic disease burden, and substantial public health spending. The U.S. has the highest number of hospitals and outpatient facilities in the region, performing millions of surgeries, injections, and diagnostic procedures annually, all of which drive demand for single‑use items like syringes, gloves, IV sets, and catheters. According to the CDC, approximately 1 in 31 hospitalized patients in the U.S. has a healthcare‑associated infection on any given day, which reinforces reliance on disposables for safety and infection prevention. Additionally, the CDC’s ongoing infection control and waste management guidelines promote use of single‑use devices to reduce cross‑contamination risks, further strengthening disposables demand. These structural, clinical, and regulatory factors make the U.S. the dominant country in the North American medical disposables market.
China has become the biggest player in the Asia Pacific medical disposables market in 2026. China has large and aging population, rising healthcare utilization, and expansion of healthcare infrastructure which collectively make it the dominant region in the Asia Pacific region. China has one of the world’s largest populations and a rapidly ageing demographic. According to the UN and Chinese government data, over 190 million people in China were aged 65 or above by the end of 2025, increasing demand for healthcare services and related consumables like medical disposables. Government initiatives such as China’s Healthy China 2030 plan aim to expand health facilities nationwide, particularly in secondary and tertiary hospitals, creating substantial demand for single‑use medical products. After COVID‑19 pandemic, China strengthened infection control standards, increasing utilization of single‑use disposables in both hospital and community settings, aligning with WHO guidelines for clinical safety.
Some of the major key players in Cognitive Systems Spending Marker are Abbott laboratories, Johnson & Johnson, Ansell Limited, Becton and Dickinson Company (BD), Boston Scientific Corporation, Medtronic Incorporated, Derma Sciences Incorporated, Kinetic Concepts, Medline Industries Inc., Cardinal Health Incorporated, Minnesota Mining and Manufacturing Company (3M Company), Young Innovations, Transcodent GmbH & Co. KG, Itamar Medical, Baxter International, and SynergEyes, Inc.
Source: BD (Becton, Dickinson and Company)
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 72.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.8% | 2033 Value Projection: | USD 98.3 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Abbott laboratories, Johnson & Johnson, Ansell Limited, Becton and Dickinson Company (BD), Boston Scientific Corporation, Medtronic Incorporated, Derma Sciences Incorporated, Kinetic Concepts, Medline Industries Inc., Cardinal Health Incorporated, Minnesota Mining and Manufacturing Company (3M Company), Young Innovations, Transcodent GmbH & Co. KG, Itamar Medical, Baxter International, and SynergEyes, Inc. |
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Source: FDA, Environmental Protection Agency
Share
Share
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
